LONDON, July 16, 2017 — The Alzheimer’s Association recognizes three leading scientists with Lifetime Achievement Awards for their contributions to advancing Alzheimer’s disease and dementia research. The awards were presented during the opening session at the Alzheimer’s Association International Conference® 2017 (AAIC® 2017) in London.
“These three scientists have made notable and valuable contributions in advancing the field of Alzheimer’s disease and dementia research,” said Maria C. Carrillo, Ph.D., chief science officer for the Alzheimer’s Association. “Their commitment to improving the lives of people living with Alzheimer’s and other dementias is inspiring. Their work is helping lead the way to a world without Alzheimer’s. We honor them for their passion, leadership and dedication.”
Khalid Iqbal, Ph.D., Bengt Winblad, M.D., Ph.D., and Henry Wisniewski, M.D., Ph.D., founded the Alzheimer’s research conference in 1988. The AAIC Lifetime Achievement Awards are named in their honor. The Awards honor individuals who have made significant fundamental contributions to Alzheimer’s research, either through a single scientific discovery or a body of work. These contributions, whether in research, leadership or mentorship, must have a lasting impact on the field and demonstrate a lifetime commitment towards progress against Alzheimer’s and dementia. The 2017 honorees are:
Khalid Iqbal, Ph.D., Lifetime Achievement Award in Alzheimer’s Disease Research
Bengt Winblad Lifetime Achievement Award in Alzheimer's Disease Research
Henry Wisniewski Lifetime Achievement Award in Alzheimer's Disease Research
The Alzheimer’s Association is committed to accelerating the global effort to eliminate Alzheimer’s disease and to recognizing the efforts of researchers who further our understanding about this devastating disease. Since 1982 the Alzheimer's Association has invested over $385 million in more than 2,500 scientific investigations. As the largest nonprofit funder of Alzheimer’s research, our International Research Grant Program is currently investing more than $100 million across 370 best-of-field active projects in 18 countries.
The Alzheimer’s Association International Conference® 2017 (AAIC®) is the largest international meeting dedicated to advancing dementia science. Each year, AAIC unites the world’s leading researchers, next generation investigators, clinicians and the care research community to share discoveries in basic and translational research that will lead to methods of prevention and treatment, and improvements in diagnosis for Alzheimer’s disease and other dementias.
AAIC 2017 home page: www.alz.org/aaic/
AAIC 2017 newsroom: www.alz.org/aaic/pressroom.asp